Guggenheim Capital LLC Ani Pharmaceuticals Inc Transaction History

Guggenheim Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Jun 02, 2020	SELL	$30.35 - $67.14 $133,995 - $296,423	-4,415 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$55.65 - $79.83 $245,694 - $352,449	4,415 New	4,415 $272,000
Q4 2018 Feb 14, 2019	SELL	$41.17 - $56.44 $250,395 - $343,268	-6,082 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$52.95 - $71.34 $61,263 - $82,540	1,157 Added 23.49%	6,082 $344,000
Q2 2018 Aug 14, 2018	SELL	$56.38 - $68.08 $2.2 Million - $2.65 Million	-38,965 Reduced 88.78%	4,925 $329,000
Q1 2018 May 15, 2018	BUY	$56.98 - $72.41 $11,339 - $14,409	199 Added 0.46%	43,890 $2.56 Million
Q4 2017 Feb 14, 2018	SELL	$53.3 - $74.56 $462,377 - $646,808	-8,675 Reduced 16.57%	43,691 $2.82 Million
Q3 2017 Nov 14, 2017	BUY	$43.46 - $52.49 $2.28 Million - $2.75 Million	52,366	52,366 $2.75 Million

211

18.7M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $930M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.